Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The report highlights early metabolic studies, selected clinical trials, and certain double-blind placebo-controlled investigations that examined markers such as: blood sugar regulation insulin sensitivity cholesterol levels impaired glucose tolerance adipose tissue activity fat release and lipolytic activity While these studies generated interest in AOD-9604 as a potential anti-obesity drug candidate , the report stresses that no authority recognizes it as an active treatment for obesity, weight loss, or human use and emphasizes that it remains designated strictly for research use
[PubMed Citation] Posner MA et al
Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee
The peptide maintains gastric mucosa integrity continuously, functioning as a natural protective agent against damage from various sources
But even so, dont expect miracles
